AETHLON MEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.36 USD | -9.51% |
|
-6.85% | -37.90% |
| Feb. 14 | Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
| Feb. 14 | Transcript : Aethlon Medical, Inc., Q3 2024 Earnings Call, Feb 14, 2024 |
Presentation Operator MessageOperator (Operator)Greetings. Welcome to the Aethlon Medical Annu...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Aethlon Medical, Inc. (Aethlon) is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections suppression, seed the spread of metastasis and inhibit the benefit of cancer therapies. The Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression. Hemopurifier helps to bind and clear multiple different glycosylated viruses, such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), Dengue, West Nile, multiple strains of influenza, Ebola, Chikungunya, smallpox, monkeypox, multiple herpes viruses, a MERS-CoV related pseudovirus, and others. Hemopurifier is used as a device for two independent indications: the treatment of individuals with advanced or metastatic cancer and the treatment of life threating viruses that are not approved therapies.
Calendar
2024-06-25
- Q4 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.36
USD
Average target price
25.05
USD
Spread / Average Target
+1,741.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -37.90% | 3.56M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- AEMD Stock
- News Aethlon Medical, Inc.
- Transcript : Aethlon Medical, Inc. - Shareholder/Analyst Call
